SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-185603
Filing Date
2018-06-06
Accepted
2018-06-06 16:06:03
Documents
2
Period of Report
2018-05-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d599494d8k.htm 8-K 20865
2 EX-99.1 d599494dex991.htm EX-99.1 156884
  Complete submission text file 0001193125-18-185603.txt   178878
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 18883875
SIC: 2834 Pharmaceutical Preparations